交易 Sumitomo Dainippon Pharma Co., Ltd. - 4506 差价合约

交易条件

• 类型该金融市场可进行差价合约交易。了解更多:差价合约: 差价合约
• 点差: 4.2
• 长仓隔夜仓息调整长仓隔夜仓息调整保证金。您的投资¥1,000隔夜仓息来自头寸全值的费用-0.01444 %(-¥3)使用杠杆的交易规模（大约值）¥20,000来自杠杆的资金 - 美元（大约值）¥19,000前往平台: -0.01444%
• 短仓隔夜仓息调整短仓隔夜仓息调整保证金。您的投资¥1,000隔夜仓息来自头寸全值的费用-0.00778 %(-¥2)使用杠杆的交易规模（大约值）¥20,000来自杠杆的资金 - 美元（大约值）¥19,000前往平台: -0.00778%
• 隔夜调整仓息时间: 21:00 (UTC)
• 货币: JPY
• 最低成交量: 1
• 保证金: 5.00%
• 证券交易所: Japan
• 交易佣金: 0%
• 保证止损溢价保证止损 (GSL) 费用仅在 GSL 被触发时收取。更多详情请参阅我们网站的“服务费用”页面。: 1%

• 保证金。您的投资: ¥1,000
• 隔夜仓息来自头寸全值的费用: -0.01444 %
  (-¥3)

• 保证金。您的投资: ¥1,000
• 隔夜仓息来自头寸全值的费用: -0.00778 %
  (-¥2)

主要统计数据

• 前收盘价: 1893.9
• 开仓: 1931.3
• 1 年变化: 77.98%
• 日区间: 1931.3 - 1974.7

交易 Sumitomo Dainippon Pharma Co., Ltd. - 4506

Sumitomo Dainippon Pharma Co., Ltd. manufactures and sells pharmaceuticals, food ingredients and additives, veterinary medicines, diagnostics, and others. The company offers pharmaceutical products, such as therapeutic agents for Parkinson's disease, depression, type 2 diabetes, systemic fungal infection, pruritus, chronic obstructive pulmonary disease, angina pectoris, and arrhythmia. It also provides atypical antipsychotic, antiepileptic, carbapenem antibiotic, and gastroprokine products; and Anderson-Fabry disease drugs. In addition, the company offers food ingredients and additives, such as polysaccharides, and seasonings, such as soups or bouillons; and chemical product materials consisting of pharmaceutical excipients, personal care products, coatings and industrial materials, and electronic materials. Further, it provides veterinary medicines for companion animals, primarily dogs and cats; and livestock comprising cattle, swine, poultry, horses, and aquacultured fish. Sumitomo Dainippon Pharma Co., Ltd. has partnerships with Healios K.K.; Keio University; RIKEN; the Center for iPS Cell Research and Application (CiRA); Kyoto University; and Aikomi Co., Ltd., as well as a joint development agreement with SanBio, Inc. The company was formerly known as Dainippon Sumitomo Pharma Co., Ltd. and changed its name to Sumitomo Dainippon Pharma Co., Ltd. in June 2014. Sumitomo Dainippon Pharma Co., Ltd. was founded in 1897 and is headquartered in Osaka, Japan. Sumitomo Dainippon Pharma Co., Ltd. is a subsidiary of Sumitomo Chemical Company, Limited.